Dominant Mycobacterium tuberculosis lineages in elderly patients born in Norway

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Kinander, Wibeke ^a   Bruvik, Torbjørn ^a   Dahle, Ulf R ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NORWAY; PUBLIC HEALTH PROBLEM; RECURRENT INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUBERCULOSIS; BACTERIUM IDENTIFICATION; BIODIVERSITY; BIRTH; CLASSIFICATION; GENETICS; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYLOGENY;

MYCOBACTERIUM TUBERCULOSIS;

AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; BIODIVERSITY; FEMALE; HUMANS; INCIDENCE; MALE; MYCOBACTERIUM TUBERCULOSIS; NORWAY; PARTURITION; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUBERCULOSIS;

EID: 77949508003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008373     Document Type: Article

References (29)

1. Malik AN, Godfrey-Faussett P (2005) Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. The Lancet Infectious Diseases 5: 174-183.
2. Dunn PL, North RJ (1995) Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect Immun 63: 3428-3437.
3. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, et al. (2007) The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation. J Immunol 179: 522-531.
4. Tsenova L, Harbacheuski R, Sung N, Ellison E, Fallows D, et al. (2007) BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 25: 5126-5132.
5. Dahle UR, Eldholm V, Winje BA, Mannsaker T, Heldal E (2007) Impact of Immigration on the Molecular Epidemiology of Mycobacterium tubercu- losis in a Low-Incidence Country. Am J Respir Crit Care Med 176: 930-935.
6. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907-914.
7. Brudey K, Driscoll J, Rigouts L, Prodinger W, Gori A, et al. (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiology 6: 23.
8. Vitol I, Driscoll J, Kurepina N, Kreiswirth B, Bennett K (2005) SpotClust: a tool to cluster spoligotype data for tuberculosis evolution and epidemiology. Recomb 2005: Cambrdige, Ma, May 14-18; 2005.
9. Liestol K, Tretli S, Tverdal A, Maehlen J (2009) Tuberculin status, socioeconomic differences and differences in all-cause mortality: experience from Norwegian cohorts born 1910-49. Int J Epidemiol 38: 427-434.
10. Flores L, Van T, Narayanan S, DeRiemer K, Kato-Maeda M, et al. (2007) Large Sequence Polymorphisms Classify Mycobacterium tuberculosis Strains with Ancestral Spoligotyping Patterns. J Clin Microbiol 45: 3393-3395.
11. Driscoll JR (2009) Spoligotyping for Molecular Epidemiology of the Mycobac- terium tuberculosis Complex. In. pp 117-128.
12. K, van-der-Werf M, Au B, Anh D, Kam K, et al. (9 A. D.) Vaccine- induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains. Emerging Infectious Diseases 15: 335-339.
13. Kremer K, van-der-Werf M, Au B, Anh D, Kam K, et al. (2009) Vaccine- induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains. Emerging Infectious Diseases 15: 335-339.
14. Fletcher HA, Donoghue HD, Michael Taylor G, van der Zanden AGM, et al. (2003) Molecular analysis of Mycobacterium tuberculosis DNA from a family of 18th century Hungarians. Microbiology 149: 143-151.
15. Lillebaek T, Dirksen A, Vynnycky E, Baess I, Thomsen V, et al. (2003) Stability of DNA Patterns and Evidence of Mycobacterium tuberculosis Reactivation Occurring Decades after the Initial Infection. The Journal of Infectious Diseases 188: 1032-1039.
16. Chan-Yeung M, Tam CM, Wong H, Leung CC, Wang J, et al. (2003) Molecular and Conventional Epidemiology of Tuberculosis in Hong Kong: a Population-Based Prospective Study. J Clin Microbiol 41: 2706-2708.
17. Chan-Yeung M, Cheung AHK, Dai DLK, Chan FHW, Kam KM, et al. (2006) Prevalence and determinants of positive tuberculin reactions of residents in old age homes in Hong Kong. The International Journal of Tuberculosis and Lung Disease 10: 892-898.
18. Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, et al. (2009) Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli. Chest 136: 420-425.
19. Cowley D, Govender D, February B, Wolfe M, Steyn L, et al. (2008) Recent and Rapid Emergence of W2Beijing Strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clinical Infectious Diseases 47: 1252-1259.
20. Tanaka MM, Francis AR (2006) Detecting emerging strains of tuberculosis by using spoligotypes. Proceedings of the National Academy of Sciences 103: 15266-15271.
21. Luciani F, Sisson SA, Jiang H, Francis AR, Tanaka MM (2009) The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences 106: 14711-14715.
22. Zhao M, Li X, Xu P, Shen X, Gui X, et al. (2009) Transmission of MDR and XDR Tuberculosis in Shanghai, China. PLoS ONE 4: e4370.
23. Gagneux S, Small PM (2007) Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. The Lancet Infectious Diseases 7: 328-337.
24. Gandon S, Mackinnon MJ, Nee S, Read AF (2001) Imperfect vaccines and the evolution of pathogen virulence. Nature 414: 751-756.
25. Stavrum R, Myneedu VP, Arora VK, Ahmed N, Grewal HMS (2009) In-Depth Molecular Characterization of Mycobacterium tuberculosis from New Delhi: Predominance of Drug Resistant Isolates of the ''Modern'' (TbD1) Type. PLoS ONE 4: e4540.
26. de Jong B, Hill P, Aiken A, Awine T, Antonio M, et al. (2008) Progression to Active Tuberculosis, but Not Transmission, Varies by Mycobacterium tuberculosis Lineage in The Gambia. The Journal of Infectious Diseases 198: 1037-1043.
27. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, et al. (2006) Variable host2pathogen compatibility in Mycobacterium tuberculosis. Pro- ceedings of the National Academy of Sciences of the United States of America 103: 2869-2873.
28. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, et al. (2008) High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography. PLoS Biol 6: e311.
29. Baranov AA, Mariandyshev AO, Mannsåker T, Dahle UR, Bjune GA (2009) Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia. The International Journal of Tuberculosis and Lung Disease 13: 1288-1293.